Genetic and environmental determinants of plasma total homocysteine levels: Impact of population-wide folate fortification

Pharmacogenetics and Genomics

Volumn 21, Issue 7, 2011, Pages 426-431

  Nagele, Peter ^a   Meissner, Konrad ^a,d   Francis, Amber ^b   Födinger, Manuela ^c   Saccone, Nancy L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c KAISER FRANZ JOSEF HOSPITAL   (Austria)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

folate fortification; folic acid; homocysteine

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; AUSTRIA; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; FEMALE; FOLATE METABOLISM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; UNITED STATES;

EID: 79959797206     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32834741ff     Document Type: Article

References (26)

1. Toffoli G, De Mattia E. Pharmacogenetic relevance of MTHFR polymorphisms. Pharmacogenomics 2008; 9:1195-1206.
2. Ulrich CM, Robien K, Sparks R. Pharmacogenetics and folate metabolism - a promising direction. Pharmacogenomics 2002; 3:299-313. (Pubitemid 34567568)
3. Robien K, Boynton A, Ulrich CM. Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 2005; 6:673-689. (Pubitemid 41479413)
4. Deacon R, Lumb M, Perry J, Chanarin I, Minty B, Halsey MJ, Nunn JF. Selective inactivation of vitamin B12 in rats by nitrous oxide. Lancet 1978; 2:1023-1024. (Pubitemid 9058888)
5. Fowler B. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med 2005; 5:77-86. (Pubitemid 40944284)
6. Nagele P, Zeugswetter B, Wiener C, Burger H, Hüpfl M, Mittlböck M, Födinger M. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology 2008; 109:36-43.
7. Nagele P, Zeugswetter B, Eberle C, Hupfl M, Mittlböck M, Fö dinger M. A common gene variant in methionine synthase reductase is not associated with peak homocysteine concentrations after nitrous oxide anesthesia. Pharmacogenet Genomics 2009; 19:325-329.
8. Bathum L, Petersen I, Christiansen L, Konieczna A, Sorensen TI, Kyvik KO. Genetic and environmental influences on plasma homocysteine: results from a Danish twin study. Clinical Chemistry 2007; 53:971-979. (Pubitemid 46744256)
9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113.
10. Jee S, Song K, ShimW, Kim H, Suh I, Park J, et al. Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography. Human Genetics 2002; 111:128-135. (Pubitemid 36075030)
11. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends in Pharmacological Sciences 2001; 22:195-201. (Pubitemid 32244306)
12. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346:1070-1071.
13. Pfeiffer CM, Osterloh JD, Kennedy-Stephenson J, Picciano MF, Yetley EA, Rader JI, Johnson CL. Trends in circulating concentrations of total homocysteine among US adolescents and adults: findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys. Clinical Chemistry 2008; 54:801-813. (Pubitemid 351671605)
14. Jacques PF, Selhub J, Bostom AG,Wilson PWF, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999; 340:1449-1454. (Pubitemid 29220543)
15. Ueland PM, Hustad S. Homocysteine and folate status in an era of folic acid fortification: balancing benefits, risks, and B-vitamins. Clinical Chemistry 2008; 54:779-781. (Pubitemid 351671592)
16. Feix A, Winkelmayer WC, Eberle C, Sunder-Plassmann G, Fö dinger M. Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis 2004; 174:43-48. (Pubitemid 38595438)
17. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64:169-172. (Pubitemid 28453294)
18. Hustad S, Midttun O, Schneede J, Vollset SE, Grotmol T, Ueland PM. The methylenetetrahydrofolate reductase 677C- >T polymorphism as modulator of a B vitamin network with major effects on homocysteine metabolism. American Journal of Human Genetics 2007; 80:846-855. (Pubitemid 46668453)
19. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, et al. The 1298A- >C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156:409-415. (Pubitemid 32522922)
20. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67:263-270. (Pubitemid 28076718)
21. Dietrich M, Brown CJP, Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 2005; 24:266-274. (Pubitemid 43193852)
22. CDC. Spina bifida and anencephaly before and after folic acid mandate- United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 2004; 53:362-365.
23. Pare G, Chasman DI, Parker AN, Zee RRY, Malarstig A, Seedorf U, et al. Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the women's genome health study. Circ Cardiovasc Genet 2009; 2:142-150.
24. Fredriksen A° , Meyer K, Ueland PM, Stein EV, Grotmol T, Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Human Mutation 2007; 28:856-865. (Pubitemid 47579935)
25. Yang Q-H, Botto LD, Gallagher M, Friedman JM, Sanders CL, Koontz D, et al. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr 2008; 88:232-246. (Pubitemid 351988705)
26. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002; 288:2023-2031. (Pubitemid 35204693)